In Vivo Analysis of Human T-Cell Leukemia Virus Type 1 Reverse Transcription Accuracy
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Several studies have indicated that the genetic diversity of human T-cell leukemia virus type 1 (HTLV-1), a virus associated with adult T-cell leukemia, is significantly lower than that of other retroviruses, including that of human immunodeficiency virus type 1 (HIV-1). To test whether HTLV-1 variation is lower than other retroviruses, a tractable vector system has been developed to measure reverse transcription accuracy in one round of HTLV-1 replication. This system consists of a HTLV-1 vector that contains a cassette with the neomycin phosphotransferase ( neo ) gene, a bacterial origin of DNA replication, and the lacZ α peptide gene region (the mutational target). The vector was replicated by trans -complementation with helper plasmids. The in vivo mutation rate for HTLV-1 was determined to be 7 × 10 −6 mutations per target base pair per replication cycle. The majority of the mutations identified were base substitution mutations, namely, G-to-A and C-to-T transitions, frameshift mutations, and deletion mutations. Mutation of the methionine residue in the conserved YMDD motif of the HTLV-1 reverse transcriptase to either alanine or valine (i.e., M188A or M188V) led to a factor of two increase in the rate of mutation, indicating the role of this motif in enzyme accuracy. The HTLV-1 in vivo mutation rate is comparable to that of bovine leukemia virus (BLV), another member of the HTLV/BLV genus of retroviruses, and is about fourfold lower than that of HIV-1. These observations indicate that while the mutation rate of HTLV-1 is significantly lower than HIV-1, this lower rate alone would not explain the low diversity in HTLV-1 isolates, supporting the hypothesis that HTLV-1 replicates primarily as a provirus during cellular DNA replication rather than as a virus via reverse transcription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Seiki, M., Hattori, S., Hirayama, Y., & Yoshida, M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3618 · Cited by 1,525
Frameshift Mutations and the Genetic Code
Streisinger, G., Okada, Y., Emrich, J., Newton, J., Tsugita, A., Terzaghi, E., & Inouye, M. (1966) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1966.031.01.014 · Cited by 1,400
Mansky, L. M., & Temin, H. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.5087-5094.1995 · Cited by 1,154
Self-citationTemin, H. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.6900 · Cited by 309 · cited 1×
“Temin speculated that this common property was the strand-transfer process (50).”
BackgroundMisalignment-mediated DNA synthesis errors
Kunkel, T. A. (1990) · Biochemistry · doi:10.1021/bi00487a001 · Cited by 299
Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia
Tamiya, S., Matsuoka, M., Etoh, K., Watanabe, T., Kamihira, S., Yamaguchi, K., & Takatsuki, K. (1996) · Blood · doi:10.1182/blood.v88.8.3065.bloodjournal8883065 · Cited by 263 · cited 1×
“It has been observed that defective proviruses represent about 25 to 40% of all HTLV-1 genomes present in lymphocytes from infected individuals (many of which are defective due to deletion mutations in gag, pol, and/or env) (16, 19, 33, 49).”
Background
Cited by
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486
Sanjuán, R., Nebot, M. R., Chirico, N., Mansky, L. M., & Belshaw, R. (2010) · Journal of Virology · doi:10.1128/jvi.00694-10 · Cited by 1,246
Self-citationSanjuán, R., & Domingo-Calap, P. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2299-6 · Cited by 947
Derse, D., Hill, S. A., Lloyd, P. A., Chung, H.-K., & Morse, B. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8461-8468.2001 · Cited by 145
“This approach has been applied previously to HTLV-1 for the analysis of the virus envelope (3) and to assess virus replication fidelity ( 21 ).”
MethodAPOBEC3G Generates Nonsense Mutations in Human T-Cell Leukemia Virus Type 1 Proviral Genomes In Vivo
Fan, J., Ma, G., Nosaka, K., Tanabe, J., Satou, Y., Koito, A., Wain-Hobson, S., Vartanian, J.-P., & Matsuoka, M. (2010) · Journal of Virology · doi:10.1128/jvi.02239-09 · Cited by 130
Metadata
- Authors
- Mansky, L. M.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2000-10-15
- Volume
- 74
- Issue
- 20
- Pages
- 9525-9531
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2114577265
- Cited by
- 83
- References
- 6
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In Vivo Analysis of Human T-Cell Leukemia Virus Type 1 Reverse Transcription Accuracy. https://app.cochat.ai/papers/10.1128/jvi.74.20.9525-9531.2000
- The paper
- Mansky, L. M. (2000). In Vivo Analysis of Human T-Cell Leukemia Virus Type 1 Reverse Transcription Accuracy. Journal of Virology. https://doi.org/10.1128/jvi.74.20.9525-9531.2000
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.